港股早評:三大指數低開 科技股弱勢 黃金股、汽車股普遍下跌
隔夜美股三大指數集體收升,中概指數跌1.63%。昨日弱勢下跌的港股繼續低開,恒指、國指均跌0.61%,恒生科技指數跌0.7%。盤面上,大型科技股普遍弱勢,騰訊跌2%,小米、快手跌1%,阿里巴巴、百度、京東、美團均下跌,網易升2.39%;國際金價下跌,黃金股普跌,業績同比轉虧,中國黃金國際跌2.32%;隔夜美股汽車股下跌,帶動港股汽車股集體低開,造車新勢力跌幅靠前;生物醫藥股、半導體股、家電股紛紛走低。另一方面,中醫藥股、啤酒股、內房股、建材水泥股多數上升,昨日大跌的風電股反彈,東方電氣升超1%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.